Senior insider sale
Chief Executive Officer at CORBUS PHARMACEUTICALS HOLDINGS, INC. — senior position signals high conviction
$470.0K
27.63K shares
What this filing means
COHEN YUVAL plans to sell 27.63K shares of CORBUS PHARMACEUTICALS HOLDINGS, INC. valued at approximately $470.0K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 10/24/2025ACC: 0001972481-25-000257
DirectorOfficer· Chief Executive Officer
Since Jan 2019
27.63K
Shares to sell
$470.0K
Approx. market value
27.63K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Stock Option Exercise
Equity Compensation
2/13/2023
27.63KTotal acquired27.63K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/13/2023 | Stock Option Exercise Equity Compensation | 27.63K | — |
| Total | 27.63K | ||
Planned & Completed Dispositions1
NasdaqPlanned
Units to sell
27.63K
Market value
$470.0K
10/24/2025
Total
Units
27.63K
Value
$470.0K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
10/24/2025 | 27.63K | $470.0K | Nasdaq | Planned |
| Total | 27.63K | $470.0K | ||